metoprolol has been researched along with Diabetes Mellitus in 37 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the development of new onset diabetes in a large cohort of patients with heart failure treated with either metoprolol or carvedilol." | 9.12 | Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET). ( Charlesworth, A; Cleland, JG; Di Lenarda, A; Lukas, MA; Metra, M; Poole-Wilson, PA; Remme, WJ; Scherhag, A; Spark, P; Swedberg, K; Torp-Pedersen, C, 2007) |
| " We compared the effect of metoprolol with placebo on mortality and cardiovascular morbidity rates in patients with diabetes mellitus who were beta-blocker naive, >or=40 years old, and undergoing noncardiac surgery." | 9.11 | The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. ( Callesen, T; Gluud, C; Jensen, G; Juul, AB; Kofoed-Enevoldsen, A; Wetterslev, J, 2004) |
| "The objective of the current study was to examine the efficacy and tolerability of the beta-blocker metoprolol succinate controlled release/extended release (CR/XL) in patients with diabetes in the Metoprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF)." | 9.11 | Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF. ( Deedwania, PC; Ghali, JK; Giles, TD; Herlitz, J; Hildebrandt, P; Kjekshus, J; Klibaner, M; Spinar, J; Stanbrook, H; Vitovec, J; Wikstrand, J, 2005) |
| "From two large scale studies in patients with suspected acute myocardial infarction we report the outcome in diabetics after treatment with either metoprolol or placebo." | 9.06 | Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies. ( Herlitz, J; Hjalmarson, A; Malmberg, K; Rydén, L, 1989) |
| "The effect of the administration of a single oral dose of placebo, oxprenolol and metoprolol on insulin-induced hypoglycemia was investigated in seven insulin-dependent diabetics in a double-blind randomized study." | 9.05 | Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in insulin-dependent diabetics. ( Bloom, SR; Keen, H; Viberti, GC, 1980) |
| "In a double-blind randomized study, the effect of the acute administration of a single oral dose of oxprenolol, a nonselective beta-blocker, and of metoprolol, a beta 1 selective blocker, on insulin-induced hypoglycemia was tested in seven normal subjects." | 9.05 | Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in normal subjects. ( Bloom, SR; Keen, H; Viberti, GC, 1980) |
| "Although prior literature suggests that metoprolol may worsen glucose control compared to carvedilol, whether this has clinical relevance among older adults with diabetes and heart failure (HF) remains an open question." | 8.02 | Risk of clinically relevant hyperglycemia with metoprolol compared to carvedilol in older adults with heart failure and diabetes. ( Dave, CV; Dejanovic, I; Gerhard, T; Horton, DB; Kobylarz, FA; Nyandege, A; Setoguchi, S; Strom, BL; Tseng, CL, 2021) |
| "To study the development of new onset diabetes in a large cohort of patients with heart failure treated with either metoprolol or carvedilol." | 5.12 | Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET). ( Charlesworth, A; Cleland, JG; Di Lenarda, A; Lukas, MA; Metra, M; Poole-Wilson, PA; Remme, WJ; Scherhag, A; Spark, P; Swedberg, K; Torp-Pedersen, C, 2007) |
| " We compared the effect of metoprolol with placebo on mortality and cardiovascular morbidity rates in patients with diabetes mellitus who were beta-blocker naive, >or=40 years old, and undergoing noncardiac surgery." | 5.11 | The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. ( Callesen, T; Gluud, C; Jensen, G; Juul, AB; Kofoed-Enevoldsen, A; Wetterslev, J, 2004) |
| "The objective of the current study was to examine the efficacy and tolerability of the beta-blocker metoprolol succinate controlled release/extended release (CR/XL) in patients with diabetes in the Metoprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF)." | 5.11 | Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF. ( Deedwania, PC; Ghali, JK; Giles, TD; Herlitz, J; Hildebrandt, P; Kjekshus, J; Klibaner, M; Spinar, J; Stanbrook, H; Vitovec, J; Wikstrand, J, 2005) |
| "To compare efficacy and safety of atenolol, methoprolol and bisoprolol, as the most usable beta-blockers, in patients with isolated systolic arterial hypertension (ISAH) and concomitant diabetes mellitus (DM) and/or chronic obstructive pulmonary disease (COPD)." | 5.10 | [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases]. ( Abakumov, IuE; Batutina, AM; Kukes, VG; Mamaev, VI; Ostroumova, OD; Zykova, AA, 2003) |
| "From two large scale studies in patients with suspected acute myocardial infarction we report the outcome in diabetics after treatment with either metoprolol or placebo." | 5.06 | Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies. ( Herlitz, J; Hjalmarson, A; Malmberg, K; Rydén, L, 1989) |
| "The effect of 2 weeks treatment with propranolol or metoprolol on skin blood flow (SBF) at rest was examined in 12 diabetic patients with essential hypertension in whom gross large vessel disease had been excluded." | 5.06 | The effects of propranolol and metoprolol on skin blood flow in diabetic patients. ( Barham, J; Hyer, SL; Shaw, J; Taylor, D; Vince, FP; Wilson, J, 1987) |
| "The effect of the administration of a single oral dose of placebo, oxprenolol and metoprolol on insulin-induced hypoglycemia was investigated in seven insulin-dependent diabetics in a double-blind randomized study." | 5.05 | Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in insulin-dependent diabetics. ( Bloom, SR; Keen, H; Viberti, GC, 1980) |
| "In a double-blind randomized study, the effect of the acute administration of a single oral dose of oxprenolol, a nonselective beta-blocker, and of metoprolol, a beta 1 selective blocker, on insulin-induced hypoglycemia was tested in seven normal subjects." | 5.05 | Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in normal subjects. ( Bloom, SR; Keen, H; Viberti, GC, 1980) |
| "Two beta-blocking agents, non-selective propranolol and beta1-selective metoprolol, were investigated with respect to their effects on glucose metabolism in 10 hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM)." | 5.05 | Influence of beta-blocking drugs on glucose metabolism in patients with non-insulin dependent diabetes mellitus. ( Gordin, A; Groop, L; Harno, K; Tötterman, KJ, 1982) |
| "Although prior literature suggests that metoprolol may worsen glucose control compared to carvedilol, whether this has clinical relevance among older adults with diabetes and heart failure (HF) remains an open question." | 4.02 | Risk of clinically relevant hyperglycemia with metoprolol compared to carvedilol in older adults with heart failure and diabetes. ( Dave, CV; Dejanovic, I; Gerhard, T; Horton, DB; Kobylarz, FA; Nyandege, A; Setoguchi, S; Strom, BL; Tseng, CL, 2021) |
| "Five patients with incipient diabetic nephropathy participated in a long-term study." | 2.66 | Acute and long-term effect of antihypertensive treatment on exercise-induced albuminuria in incipient diabetic nephropathy. ( Christensen, CK; Mogensen, CE, 1986) |
| " This study assesses the impact of β-blocker type and dosing on survival in patients with DM after MI." | 1.91 | Impact of Diabetes Mellitus on Benefit of β-Blocker Therapy After Myocardial Infarction. ( Abbott, JD; Bello, D; Blandon, C; Goldberger, JJ; Subačius, H; Zaatari, G, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (70.27) | 18.7374 |
| 1990's | 1 (2.70) | 18.2507 |
| 2000's | 6 (16.22) | 29.6817 |
| 2010's | 2 (5.41) | 24.3611 |
| 2020's | 2 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Zaatari, G | 1 |
| Bello, D | 1 |
| Blandon, C | 1 |
| Abbott, JD | 1 |
| Subačius, H | 1 |
| Goldberger, JJ | 1 |
| Dave, CV | 1 |
| Strom, BL | 1 |
| Kobylarz, FA | 1 |
| Horton, DB | 1 |
| Gerhard, T | 1 |
| Tseng, CL | 1 |
| Dejanovic, I | 1 |
| Nyandege, A | 1 |
| Setoguchi, S | 1 |
| Duan, L | 1 |
| Ng, A | 1 |
| Chen, W | 1 |
| Spencer, HT | 1 |
| Nguyen, J | 1 |
| Shen, AY | 1 |
| Lee, MS | 1 |
| Giles, TD | 2 |
| Remme, WJ | 2 |
| Kukes, VG | 1 |
| Ostroumova, OD | 1 |
| Mamaev, VI | 1 |
| Batutina, AM | 1 |
| Abakumov, IuE | 1 |
| Zykova, AA | 1 |
| Juul, AB | 1 |
| Wetterslev, J | 1 |
| Kofoed-Enevoldsen, A | 1 |
| Callesen, T | 1 |
| Jensen, G | 1 |
| Gluud, C | 1 |
| Deedwania, PC | 1 |
| Klibaner, M | 1 |
| Ghali, JK | 1 |
| Herlitz, J | 2 |
| Hildebrandt, P | 1 |
| Kjekshus, J | 1 |
| Spinar, J | 1 |
| Vitovec, J | 1 |
| Stanbrook, H | 1 |
| Wikstrand, J | 1 |
| Kveiborg, B | 1 |
| Christiansen, B | 1 |
| Major-Petersen, A | 1 |
| Torp-Pedersen, C | 2 |
| Metra, M | 1 |
| Charlesworth, A | 1 |
| Spark, P | 1 |
| Lukas, MA | 1 |
| Poole-Wilson, PA | 1 |
| Swedberg, K | 1 |
| Cleland, JG | 1 |
| Di Lenarda, A | 1 |
| Scherhag, A | 1 |
| Viberti, GC | 2 |
| Keen, H | 2 |
| Bloom, SR | 2 |
| Lager, I | 3 |
| Jagenburg, R | 1 |
| von Schenck, H | 1 |
| Smith, U | 4 |
| Merker, R | 1 |
| Schwittek, W | 1 |
| Kladetzky, RG | 1 |
| Kuhn, H | 1 |
| Groop, L | 2 |
| Tötterman, KJ | 3 |
| Harno, K | 2 |
| Gordin, A | 2 |
| Kølendorf, K | 2 |
| Jensen, HA | 1 |
| Holst, JJ | 1 |
| Poulsen, JE | 1 |
| Parving, HH | 1 |
| Andersen, AR | 1 |
| Smidt, UM | 1 |
| Svendsen, PA | 1 |
| Micossi, P | 1 |
| Pollavini, G | 1 |
| Raggi, U | 1 |
| Librenti, MC | 1 |
| Garimberti, B | 1 |
| Beggi, P | 1 |
| Groop, LC | 1 |
| Ostman, J | 2 |
| Arner, P | 2 |
| Haglund, K | 2 |
| Julin-Dannfelt, A | 1 |
| Novac, J | 1 |
| Wennlund, A | 2 |
| Holm, G | 1 |
| Johansson, S | 1 |
| Vedin, A | 1 |
| Wilhelmsson, C | 1 |
| Garrett, BN | 1 |
| Raskin, P | 1 |
| Kaplan, NM | 1 |
| Bonnevie-Nielsen, V | 1 |
| Broch-Møller, B | 1 |
| Juhlin-Dannfelt, A | 1 |
| Nowak, J | 1 |
| Shepherd, AM | 1 |
| Lin, MS | 1 |
| Keeton, TK | 1 |
| Woods, KL | 1 |
| Wright, AD | 2 |
| Kendall, MJ | 2 |
| Black, E | 1 |
| Massara, F | 1 |
| Camanni, F | 1 |
| Molinatti, GM | 1 |
| Blohmé, G | 1 |
| Barber, SG | 1 |
| Poole, PH | 1 |
| Lundgren, H | 1 |
| Bengtsson, C | 1 |
| Lapidus, L | 1 |
| Bengtsson, L | 1 |
| Cruickshank, JK | 1 |
| Anderson, NM | 1 |
| Wadsworth, J | 1 |
| Young, SM | 1 |
| Jepson, E | 1 |
| Malmberg, K | 1 |
| Hjalmarson, A | 1 |
| Rydén, L | 1 |
| Lithell, H | 1 |
| Pollare, T | 1 |
| Berne, C | 1 |
| Christensen, CK | 1 |
| Mogensen, CE | 1 |
| Hyer, SL | 1 |
| Taylor, D | 1 |
| Barham, J | 1 |
| Wilson, J | 1 |
| Shaw, J | 1 |
| Vince, FP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Propranolol as a Treatment for Impaired Awareness of Hypoglycemia in Type 1 Diabetes[NCT03161964] | Phase 2 | 2 participants (Actual) | Interventional | 2017-10-19 | Terminated (stopped due to Statistical power could not be achieved due to low enrollment.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for metoprolol and Diabetes Mellitus
| Article | Year |
|---|---|
Use of beta-blockers for heart failure in patients with diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Diabetes C | 2002 |
Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Diabetes Mellitus; Glucose; Humans; In | 2006 |
22 trials available for metoprolol and Diabetes Mellitus
| Article | Year |
|---|---|
[Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambula | 2003 |
The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Diabetes Complications; Diabetes Mellit | 2004 |
Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Delayed-Action Preparations; Diabetes Complications; Diabe | 2005 |
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
Topics: Adrenergic beta-Antagonists; Aged; Blood Glucose; Carbazoles; Carvedilol; Chi-Square Distribution; D | 2007 |
Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in insulin-dependent diabetics.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Pressure; Diabetes Mellitus; Fatty Acids, N | 1980 |
Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in normal subjects.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Diabetes Mellitus; Fatty Acids, Nonesterified; F | 1980 |
Effect of beta-blockade on hormone release during hypoglycaemia in insulin-dependent diabetics.
Topics: Adrenergic beta-Antagonists; Adult; Alanine; Blood Glucose; Catecholamines; Diabetes Mellitus; Femal | 1980 |
Influence of beta-blocking drugs on glucose metabolism in patients with non-insulin dependent diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Doubl | 1982 |
Influence of beta-blocking drugs on glucose metabolism in hypertensive, non-diabetic patients.
Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Double-Blind Method; Fatty | 1983 |
No effect of propranolol and metoprolol on tolbutamide-stimulated insulin-secretion in hypertensive diabetic and non-diabetic patients.
Topics: Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Hu | 1982 |
The effect of beta-blockade on glucose tolerance and insulin release in adult diabetes.
Topics: Administration, Oral; Aged; Alprenolol; Blood Glucose; Diabetes Mellitus; Diet, Diabetic; Female; Gl | 1980 |
A trial of metoprolol in hypertensive insulin-dependent diabetic patients.
Topics: Adult; Aged; Benzothiadiazines; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; | 1982 |
Effect of metoprolol and alprenolol on the metabolic, hormonal, and haemodynamic response to insulin-induced hypoglycaemia in hypertensive, insulin-dependent diabetics.
Topics: Adult; Alprenolol; Diabetes Complications; Diabetes Mellitus; Female; Hemodynamics; Humans; Hyperten | 1982 |
Lack of effect of propranolol and metoprolol on glucose tolerance in maturity-onset diabetics.
Topics: Diabetes Mellitus; Glucose Tolerance Test; Humans; Metoprolol; Propanolamines; Propranolol | 1980 |
Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics.
Topics: Adult; Blood Glucose; Blood Pressure; Bradycardia; Clinical Trials as Topic; Diabetes Mellitus; Dias | 1979 |
Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Dou | 1979 |
Antihypertensive drugs and glucose metabolism: comparison between a diuretic, a beta-blocker and felodipine, a new calcium antagonist in subjects with arterial hypertension and diabetes.
Topics: Aged; Blood Glucose; Diabetes Mellitus; Double-Blind Method; Felodipine; Female; Glucose Tolerance T | 1990 |
Treating hypertensive diabetics: a comparison of verapamil and metoprolol in black and white patients.
Topics: Albuminuria; Black People; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Complications; Diabe | 1987 |
Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies.
Topics: Diabetes Complications; Diabetes Mellitus; Humans; Metoprolol; Multicenter Studies as Topic; Myocard | 1989 |
Effects of long-term antihypertensive treatment on glucose metabolism.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus; Dilt | 1989 |
Acute and long-term effect of antihypertensive treatment on exercise-induced albuminuria in incipient diabetic nephropathy.
Topics: Adult; Albuminuria; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Nephropath | 1986 |
The effects of propranolol and metoprolol on skin blood flow in diabetic patients.
Topics: Adult; Aged; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hypertension; Male; Metoprol | 1987 |
13 other studies available for metoprolol and Diabetes Mellitus
| Article | Year |
|---|---|
Impact of Diabetes Mellitus on Benefit of β-Blocker Therapy After Myocardial Infarction.
Topics: Adrenergic beta-Antagonists; Carvedilol; Diabetes Mellitus; Humans; Metoprolol; Myocardial Infarctio | 2023 |
Risk of clinically relevant hyperglycemia with metoprolol compared to carvedilol in older adults with heart failure and diabetes.
Topics: Aged; Carvedilol; Diabetes Mellitus; Heart Failure; Humans; Hyperglycemia; Male; Medicare; Metoprolo | 2021 |
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi | 2017 |
Which beta-blocker is most effective in heart failure?
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Clinical Tria | 2010 |
[Serum lipid levels under chronical treatment with beta-receptor blocking agents in patients with coronary artery disease (author's transl)].
Topics: Adrenergic beta-Antagonists; Alcohol Drinking; Cholesterol; Coronary Disease; Diabetes Mellitus; Hum | 1981 |
Effect of acute selective beta-1-adrenoceptor blockade on hormonal and cardiovascular response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Glucose; Diabetes Mellitus; Epinephr | 1982 |
Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus; Diabetic Nephropathies; Diuretics | 1983 |
Effects of metoprolol and propranolol on glucose tolerance and insulin secretion in diabetes mellitus.
Topics: Adult; Aged; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; | 1984 |
A cardio-selective beta blocker (metoprolol) in hypertensive, insulin-dependent diabetics. A preliminary report.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Diabetes Mellitus; Female; Humans; Hypertension; Hypogly | 1980 |
Metoprolol in diabetes mellitus: effect on glucose homeostasis.
Topics: Aged; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Homeostasis; Human | 1980 |
Hypoglycemia-induced hypertension in a diabetic patient on metoprolol.
Topics: Blood Glucose; Blood Pressure; Diabetes Mellitus; Epinephrine; Humans; Hypoglycemia; Hypotension; Ma | 1981 |
Plasma potassium and adrenergic system.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Diabetes Mellitus; Humans; Insulin | 1978 |
Beta blockade in diabetes.
Topics: Cardiovascular System; Diabetes Mellitus; Humans; Hypoglycemia; Metoprolol; Propanolamines; Proprano | 1978 |